lpm3770164
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 28, 2022 (NCT05238701)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Synaptic vesicular amine transporterINHIBITOR
SLC18A2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06731868 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2024 | Luye Pharma |
| NCT06474650 | Phase 1 | Aug 31, 2024 | Jiao Tong University, Luye Pharma |
| NCT06216054 | Phase 1 | Dec 23, 2023 | Jiao Tong University, Luye Pharma |
| NCT05238701 | Phase 1 | Feb 28, 2022 | Jiao Tong University, Luye Pharma |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Luye Pharma | For profit | 4 | 4 | 2 | 2022 |
| Jiao Tong University | Academic/Hospital | 3 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1